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Subsequent to global initiatives in mapping the human brain and investigations of neurobiological 
markers for brain disorders, the number of multi-site studies involving the collection and sharing of 
large volumes of brain data, including electroencephalography (EEG), has been increasing. Among the 
complexities of conducting multi-site studies and increasing the shelf life of biological data beyond the 
original study are timely standardization and documentation of relevant study parameters. We present 
the insights gained and guidelines established within the EEG working group of the Canadian Biomarker 
Integration Network in Depression (CAN-BIND). CAN-BIND is a multi-site, multi-investigator, and multi-
project network supported by the Ontario Brain Institute with access to Brain-CODE, an informatics 
platform that hosts a multitude of biological data across a growing list of brain pathologies. We describe 
our approaches and insights on documenting and standardizing parameters across the study design, 
data collection, monitoring, analysis, integration, knowledge-translation, and data archiving phases of 
CAN-BIND projects. We introduce a custom-built EEG toolbox to track data preprocessing with open-
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access for the scientific community. We also evaluate the impact of variation in equipment setup on the 
accuracy of acquired data. Collectively, this work is intended to inspire establishing comprehensive and 
standardized guidelines for multi-site studies.
The common global interest in discovering early predictors and interventions for a host of debilitating brain 
disorders has led to an increasing number of collaborative multi-site research studies and collection of large 
volumes of biological data. To this end, big data informatics platforms and technological tools have emerged to 
empower the sharing and integration of biological data across projects, laboratories, and countries. Examples 
of these initiatives include: large-scale global initiatives to integrate neuroimaging and genetic data across neu-
ropsychiatric pathologies from numerous laboratories such as the ENIGMA (Enhancing NeuroImaging Genetics 
through Meta-Analysis (ENIGMA) Consortium)1; multicentre clinical trials aimed at identifying predictors of 
response to treatments in specific pathologies such as EMBARC (Establishing Moderators and Biosignatures 
of Antidepressant Response in Clinical Care2); and multi-site, multi-investigator, and multi-project initiatives 
involving the collection of a host of biological data aimed at transforming treatment of specific pathologies such 
as the Canadian Biomarker Integration Network in Depression (CAN-BIND)3, 4 initiative of the Ontario Brain 
Institute5. Historically, genetic and structural magnetic resonance imaging (MRI) data have been the primary 
focus of most biological big data consortiums. However, a growing understanding of the pivotal role of change 
in brain function and dynamicity in various pathologies has led to the inclusion of functional neuroimaging data 
in many multi-site studies. Particularly, the real world application (e.g., portability and cost) of scalp-recorded 
electrophysiological signals through electroencephalography (EEG) has led to a number of multi-site EEG studies 
(e.g., ref. 2, 4). Likewise, there has been a growing interest in the meta-analysis of unstructured EEG data col-
lected across laboratories. While the establishment of standardized analytic toolboxes for genetic and structural 
MRI data has, over the years, reduced the need for extensive communication between investigators in multi-site 
studies involving such structural data6, additional work is required to simplify the process of data integration for 
functional neuroimaging or neurophysiological data such as EEG. To date, very few initiatives, guidelines, stand-
ardized toolboxes, or general study design frameworks exist to guide collection and integration of large-scale 
EEG data7, 8.
The first step in multi-site EEG data collection and integration is the identification and assessment of sources 
of variability that can impact the EEG outcomes. Inter-dataset variability in EEG studies can originate from errors 
or differences in study designs, equipment, experimental setup, data quality control procedures, or data preproc-
essing and analyses. Within each of these categories, factors which affect study outcomes may be obvious and con-
trolled for at the time of study design. However, such factors may not emerge in the early phases of study design, 
such as when projects are designed by multiple teams of scientists or when data integration is not planned a priori.
The overarching aim of this paper is to provide insights and solutions that thus far have emerged from the 
work of the CAN-BIND EEG group and to contribute to the ongoing effort of standardized multi-site EEG stud-
ies. We describe scenarios that initiated the development of standardized methodologies and guidelines across 
various phases of this multi-site EEG study, from design to data dissemination. Specifically, we draw examples 
from the first (out of currently nine and growing) multi-site and multi-investigator CAN-BIND project focused 
on the identification of EEG biomarkers of response to escitalopram and aripiprazole. The study protocol of this 
project has been previously published and interested readers are referred to prior publications for a detailed 
description of the study design and rationale3, 4. In current article, project-specific description is mainly provided 
in the context of data standardization.
Results
In EEG studies, inter-dataset variability can emerge due to errors or differences in: 1) study design, 2) equipment, 
software and laboratory setting, 3) acquisition parameters, 4) data collection monitoring procedures, 5) quality 
control procedures prior to data sharing, 6) parameters and algorithms used in data pre-processing, 7) EEG 
feature extraction algorithms, 8) the choice of statistical frameworks, 9) data archiving processes, and 10) the 
method of knowledge translation (Fig. 1). Next, we will discuss the EEG-specific and general considerations listed 
above, as well as guidelines that we have put together to reduce bias and variability within each of these categories.
Study design. A number of key study design considerations should be followed in multi-site EEG studies. 
These include: determining the proper sequence of data collection, planning for data integration, standardizing 
the time of day for data collection, standardization of instructions given to participants prior to EEG visits, and 
annotating the collected data with parameters that may differ across studies.
Sequence of data collection. Study protocols should describe plans for controlling the bias introduced by the 
sequential application of a study procedure, especially when similar study procedures are conducted using dif-
ferent modalities of neuroimaging procedures. For example, if participants are required to perform the same task 
using EEG and functional MRI (fMRI), the order of modalities may need to be randomized to not introduce 
systematic biases due to practice effects. Specifically, every effort should be made to keep the randomization 
procedure similar across sites and between patients and controls. As described next, other study designs may be 
considered if integrative analyses are desired.
Planning for data integration. Integrative analyses (in which input variables span different platforms) should be 
discussed and planned prior to study launch. When integrative analyses across multiple platforms (e.g., EEG and 
fMRI) are expected, study protocols should include methodological and statistical plans for data integration. As 
an example, if the aim of administering a behavioral task or condition (e.g., resting-state) using several modalities 
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is to combine the results from all modalities into a single comprehensive outcome — for example, quantify the 
same neural mechanism using both EEG and fMRI — then caution should be exercised to keep the parameters 
of the task and experimental conditions as similar as possible between the modalities. This can be challenging 
in the case of a behavioral task, as the rate (frequency of stimuli presentation) and number of stimuli presented 
are tailored for each modality specifically (e.g., more stimuli are presented for EEG to increase the signal to noise 
ratio with lower rates of presentation used in fMRI). Moreover, the resting-state condition in MRI studies involves 
participants lying down on the MRI table while subjected to loud auditory background noise of the MRI machine. 
In EEG, on the other hand, the resting-state condition often involves an upright sitting position with no system-
atic exposure to loud auditory noise. These differences may lead to activation of different neural mechanisms 
across modalities. To minimize the possibility of activating different mechanisms, the tasks and conditions should 
be kept as similar as possible between the two modalities. Alternatively, investigators may consider concurrent 
multi-modal data collection (e.g., concurrent EEG and fMRI). However, this would require access to fMRI com-
patible EEG units and extensive denoising procedures to remove MRI artifact from EEG. Collectively, these issues 
must be discussed and planned among investigators of platforms early on and preferably prior to study launch.
Time of data collection. Efforts should be made to keep the time of data collection consistent across sites and 
within subjects. Fluctuations in circadian rhythms could impact functional data (e.g., EEG)8. This can lead to 
inter-site biases if there are differences in the time of data collection between sites. The time of EEG collection 
should also not significantly differ across the studied groups (e.g., patients and controls) and within groups (e.g., 
longitudinal assessment). This may be challenging due to variability in the availability of EEG laboratory space 
across the participating sites. In such instances, data must be annotated to permit post-hoc assessment for impact 
of “time of day” on the outcomes. Finally, as discussed next, standardized instructions should be given to par-
ticipants across different sites and studies to avoid data collection under sleep deprivation. For example, a set of 
standardized instructions could be sent to participants prior to each study visit to remind them that they should 
get a full night sleep and cancel their study visit if they are unable to do so.
Standardization of instructions given to participants prior to EEG visits. EEG signals are composed of both trait 
and state components. In order to reduce the level of noise in the state component, it is crucial to develop a stand-
ard operating procedure (SOP) to instruct subjects about aspects such as sleep hygiene, caffeine intake, smoking 
habit, alcohol intake before EEG. Such SOP should aim at decreasing the noise caused by those parameters rather 
than rigid prescriptive rules. In this regard, compliance with SOP should be monitored in a way that promotes 
participants’ reporting of deviations from the prescription. The reporting of deviation(s) from the SOP should be 
carefully and systematically documented in data annotation procedures described next.
Data annotation. It is of the essence to establish a clear and consistent naming convention that is strictly fol-
lowed across sites. This is critical as studies may include multiple tasks and conditions, several groups and time 
points if longitudinal data are collected. Compliance with naming convention should be monitored throughout 
the study, and particularly at the onset of the study. The type and volume of technical and demographic infor-
mation collected at the time of the EEG experiment could be potentially essential in accounting for non-specific 
effects and controlling for potential confounds. This may also enhance the probability of data reusability and inte-
gration in the future. Examples include but are not limited to: time of data collection; consumption of caffeinated 
drinks, over-the-counter medications (e.g., antihistamines or non-steroid anti-inflammatory drugs), or tobacco 
smoking immediately prior to data collection; consumption of alcoholic beverages in the last 24 hours; rigorous 
physical exercise or consumption of a heavy meal immediately prior to the EEG session; phase of menstrual cycle; 
results of urine drug tests; hours of sleep the night prior to the EEG visit; drowsiness during the experiment; 
and other demographic information including handedness, years of education, musicianship, sportsmanship, 
Figure 1. Potential Sources of Variance in Multi-Site EEG Studies. This flowchart summarizes the major phases 
of an EEG study in chronological order. For each phase, the diagram lists items/parameters/guidelines that need 
to be standardized in multi-site/multi-project/multi-investigator EEG studies.
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and bilingualism. As will be discussed next, the make and model of equipment and software used in EEG stud-
ies should also be reported. The list of metadata currently captured from multi-site EEG studies hosted on the 
Brain-CODE informatics platform can be found on Brain-CODE website (https://www.braincode.ca/sites/
default/files/about/BraincodeStandardEEGDataCollectionForm%282015%29.pdf).
Selection of equipment, software and laboratory setting. Ideally, every effort should be made 
to keep the equipment and experimental conditions consistent across sites and certainly between groups (e.g. 
patient vs. control), as well as within subjects (i.e. in longitudinal designs were there are multiple data points 
captured). This may include: EEG equipment model, EEG acquisition software, EEG task software and version 
number, computer operating systems, room temperature, amount and nature of lightening in the EEG laboratory 
and level of ambient noise (e.g., sound, electromagnetic noise). In the event that these conditions cannot be kept 
consistent across sites, site-specific information on these conditions should be collected, archived, and shared for 
post-hoc evaluation of their impact on EEG outcome measures.
EEG studies measuring neural responses time-locked to the onset of a stimulus, such as event-related poten-
tials (ERPs), should evaluate the synchrony between the stimulus presentation system (task computer) and the 
EEG data recording system (EEG computer). This is to account for the time delay between the true onset of a 
stimulus, as seen or heard by the participant, and the onset of the stimulus marked in the EEG data file. Such 
timing issues may arise when the task computer takes time to initialize the hardware required for stimulus pres-
entation. This may be due to the presence of background computer processes or various inconsistencies with the 
stimulus presentation software. In general, users must take the necessary precautions to account for this time 
delay and its variation (i.e., jitters) as a function of operating systems or hardware models involved in stimulus 
presentation.
We conducted a series of experiments to evaluate the amount and variation of this time delay for two modes 
of stimuli (auditory and visual) across two different computer models/operating systems (Lenovo ThinkCentre 
M72e-3660 with Windows XP and Dell Optiplex 7020 with Windows 7) (Table 1). Moreover, for the visual stim-
ulus, we set to examine whether this delay varied across monitor models. In our experiments, the stimulus pres-
entation software was E-prime (Psychology Software Tools, Inc.) and the EEG system was Neuroscan Synamps 
2/RT (Compumedics, USA). To bypass the delays associated with operating systems and accurately measure the 
true onset time of stimuli, a commercially-available device, StimTracker (StimTracker, Cedrus, San Pedro, CA, 
USA) was used.
To assess the precision of StimTracker, a supplementary experiment was conducted. Two scenarios were con-
trasted using auditory stimuli. In the first scenario (Fig. 2B), the true onset time of an auditory stimulus was 
detected by directly connecting the audio signal to the EEG amplifier through bipolar EEG channels. This audio 
signal was attenuated to avoid amplifier saturation. In the second scenario (as shown in Fig. 2C), StimTracker 
was used to detect the true onset of the auditory stimulus by directly monitoring the audio output from the task 
computer. In both scenarios, the EEG computer records the event marker associated with the onset of the stimuli 
sent by the E-Prime computer (seen as a blue vertical line in Fig. 2B,C). Results showed that StimTracker could 
accurately measure the time delay in stimulus presentation.
In all subsequent tests, StimTracker was used to assess the described time delay across computer models/
operating systems and monitors. During these tests, StimTracker was configured to receive timing information of 
stimuli (true stimuli onset and onset of triggers sent from E-Prime computer) and relay this information to the 
EEG system (Fig. 2A). To measure the true onset of a visual stimulus, a photosensor was used to detect a white 
visual stimulus on the monitor connected to the E-Prime computer. To measure the true onset of an auditory 
stimulus, an audio cable was connected from the task computer to StimTracker to detect auditory stimuli. To 
record the event marker sent by E-prime software to the EEG recording computer, the event marker was con-
verted to a TTL signal using a DB25-to-RJ45 adapter. The time delay was then calculated as the “true onset of 
stimulus” minus the “actual onset marked in the EEG system”. A summary of the measured delay times are shown 
in Table 1 for a number of scenarios.
Stimulus Type Operating System Equipment Info
Measured Delay (ms) 
+/− Std Dev
Auditory
Windows XP SP3 (32-bit System) on 
Lenovo ThinkCentre M72e-3660
Direct Sound – Primary Sound 
Driver 24.6 +/− 0.59
Windows 7 Professional SP1 (64-bit 
System) On Dell Optiplex 7020
Direct Sound – Primary Sound 
Driver 49.3 +/− 2.93
Visual
Windows XP SP3 (32-bit System) on 
Lenovo ThinkCentre M72e-3660
Lenovo ThinkVision 19-inch 
Wide LED-backlit LCD monitor 
(LT1952pwD)
Centre: 19.3 +/− 0.91 
Corner: 29.4 +/− 1.2
Dell UltraSharp 24-inch Monitor 
with LED Backlight (U2412Mb)
Centre: 12.4 +/− 0.045 
Corner: 20.1 +/− 0.098
Windows 7 Professional SP1 (64-bit 
System) on Dell Optiplex 7020
Lenovo ThinkVision 19-inch 
Wide LED-backlit LCD monitor 
(LT1952pwD)
Centre: 18.7 +/− 1.1 
Corner: 30.4 +/− 1.3
Dell UltraSharp 24-inch Monitor 
with LED Backlight (U2412Mb)
Centre: 12.8 +/− 0.095 
Corner: 22.4 +/− 0.37
Table 1. The Time Delays in Event-Related Potential Studies Associated with an Auditory or Visual Stimulus 
over Different Operating Systems and Hardware Setups
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As illustrated in Table 1, the delay time associated with an auditory stimulus is much larger and more variable 
on a Windows 7 system (+/−2.93 ms) compared to a Windows XP system (+/−0.59 ms). Delays in the visual 
stimuli were not significantly different between the two operating systems. However, the delays were significantly 
different depending on the type of monitor and the location of the visual stimulus. Finally, the time delay of stim-
ulus presentation was found to increase over sequential trials (up to 2 ms accumulation) before it resets.
Collectively, these findings suggest that multi-site research studies should be aware of these sources of variance 
in the data. Time delays in stimulus presentation should be accounted for to minimize inter-site variance. This 
can be done either by measuring and documenting the time delays associated with each equipment setup at each 
site using similar tests as described here, or by using the same equipment model, operating systems, and monitors 
across all sites.
EEG acquisition parameters. Acquisition parameters should also be standardized across sites at the time 
of EEG collection and/or post-hoc, during data pre-processing.
In standardizing EEG parameters across sites, the site(s) with the most limited equipment condition (e.g., least 
number of EEG electrodes, lowest sampling rate, lack of flexibility in selection of reference electrode, etc) would 
dictate the lower boundary of EEG data acquisition parameters. Then, other sites could choose one of two strat-
egies: (1) either set their acquisition parameters to this lower boundary, or (2) choose parameters that can later 
on (offline) be reduced to match this lower boundary. The latter approach has the advantage of maximizing the 
chance for future data integration with other studies that are not a priori planned. In general, the less restricted 
the acquisition parameters, the higher the probability of data reusability. However, caution should be exercised to 
not introduce other sources of variations in the experiment setup as a result of using different acquisition param-
eters. For example, let’s assume a scenario in which one study site has access to a 128-channel EEG system, while 
another has access to a 19-electrode system. In this case, the time allocated for EEG cap preparation may signifi-
cantly differ between the two sites. As a result, the participants undergoing the 128-channel EEG recording may 
potentially experience more fatigue due to the long and uncomfortable EEG cap preparation procedure. This may 
then influence the subject’s performance if a cognitive task is involved. Therefore, to remedy this situation, EEG 
sites with access to 128 channel system may choose to prepare a subset of channels that are common with other 
sites. Alternatively, a quick questionnaire may be administered at all sites after each EEG session to rate subject’s 
fatigue at each site and use this information as covariate.
Monitoring the data collection procedure. In addition to standardizing EEG data acquisition param-
eters, standardized strategies should be employed to monitor data acquisition across sites. These standardized 
strategies include, but are not limited to: ensuring a common check-list is followed at each site to minimize 
Figure 2. Measuring Time Delays in Task-based Multi-Site EEG Studies. (A) Setup of StimTracker system to 
measure the delay between the exact time of stimulus presentation (on E-Prime PC) and the time at which 
the stimulus onset was marked by the physiological data system (in EEG PC) (StimTracker diagram adapted 
from Cedrus website: http://cedrus.com/support/stimtracker/tn1460_st100_pins.htm) (B) Example of delay 
measurement when an audio signal is directly measured by the EEG system. (C) Example of auditory stimulus 
delay measurement with StimTracker system. The figure was drawn by authors using Lucidchart (Lucid Software 
Inc, UT, USA).
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human error during EEG data collection (e.g., consistent EEG cap preparation procedure, lowering the electrode 
impedance to an a priori decided threshold level (e.g., <5 kOhm) and maintaining it over the entire recording ses-
sion, selection of appropriate acquisition parameters, providing identical instructions to participants across sites, 
ensuring event triggers are encoded in EEG, etc). In the case of human errors or unexpected hardware issues (i.e., 
disconnected electrodes), detailed comments must be noted and logged at the time of the EEG session. Finally, if 
feasible, dedicated research personnel could visit all EEG sites early on in the data collection phase of the projects 
to ensure all sites follow the agreed upon SOPs.
Quality control prior to data sharing. In multi-site studies that employ a common informatics platform 
for data sharing and archiving (as in CAN-BIND), the quality of data should be investigated prior to data sharing. 
This step ensures that each uploaded file adheres to the elected standards of data acquisition: for example, quality 
control step can ensure the planned acquisition parameters and data annotation are followed and data files are not 
corrupted. Additional quality control or data security steps may be considered as well. For example, EEG headers 
may be scanned for any patient information to ensure that uploaded data are de-indentified. A semi-automated 
data quality control script may be run to check each file for quality of recording (e.g. level of noise, disconnected 
electrodes, etc.) and notify sites if agreed upon standards are not followed.
EEG data pre-processing. In CAN-BIND, we have thus far implemented two levels of standardized data 
pre-processing modules for study investigators (see below). Although investigators are not obliged to use these 
pipelines for all manuscripts, these methods serve as our core standards for data preprocessing. Any deviation 
from these standards must be scientifically justified.
Pre-Processing Module 1. The aim of the first data pre-processing module is to minimize raw data heterogeneity 
across sites and prepare the data for integration. If unique acquisitions systems are used between CAN-BIND sites 
it is crucial that the raw data files be re-configured into the same file format and composition. This can be done in 
MATLAB (The Mathworks, Inc., Natick, MA, USA) via the open-source EEGLAB toolbox9. During this process, 
the data is also downsampled (e.g., sampling rate and electrode montages are reduced) and re-referenced such 
that data from all sites are converted to have equivalent sampling rate, bandwidth, electrodes, reference, and event 
matrix. In CAN-BIND, this pre-processing step has thus far been conducted by dedicated research personnel 
and the converted data files are in EEGLAB format (*.set) which are shared on the Brain-CODE EEG platform.
An important step in this pre-processing stage is to address the variety of recording channels and their asso-
ciated layouts. There are currently no established guidelines in place for integrating data between acquisition 
systems. When standard systems are used across acquisition systems (e.g., 10-10 EEG system), one way to address 
this issue is to find the closest equivalent electrodes between layouts (approach currently adapted in CAN-BIND 
projects). This approach has a downside when a standard montage (e.g., 10-10 EEG system) is not used across 
all or most sites. In such a case, a large proportion of electrodes may not have equivalents thereby resulting in a 
loss of spatial resolution and potentially impacting the types of EEG analyses that can be performed. For added 
accuracy, investigators may also choose to digitize the three-dimensional representation of the electrode lay-
out and skull shape for every EEG recording session through commercially available digitizers (e.g. Polhemus 
Patriot digitizer). Including this information with each EEG recording could also provide a means to account for 
issues related to human error in proper EEG cap placement and improve accuracy in the interpretation of EEG 
outcomes.
Pre-Processing Module 2. The aim of the second pre-processing module is to standardize and track EEG data 
through the noise removal procedure. For this purpose, to streamline the process of EEG data cleaning, we devel-
oped an open-source MATLAB application, ERPEEG toolbox, depicted in Fig. 3. This toolbox is developed in 
MATLAB (R2013a) and built using the EEGLAB platform (v.12.0.2.6b; ref. 9). A copy of this toolbox can be 
downloaded from www.tmseeg.com/multisiteprojects. The ERPEEG toolbox is created following the same frame-
work as TMSEEG toolbox10. TMSEEG toolbox enables processing of EEG collected during Transcranial Magnetic 
Stimulation (TMS-EEG)11 (e.g., standardized processing of TMS evoked potentials or TEPs), while ERPEEG is 
intended for processing of resting-state EEG and ERPs (Event-related potentials).
This toolbox has a main interactive graphical user interface (GUI) (Fig. 3A) that allows users access to the 
dataset working folder, a sequential list of pre-processing procedures, and the settings menu. Clicking on each 
step opens another interactive GUI with several data visualization suites designed for each specific processing 
step. The order of data processing steps in ERPEEG is standardized, and is optimized towards improving perfor-
mance of each processing step. For example, random and large amplitude artifacts are processed early in the pipe-
line in order to increase the performance of the independent component analysis (ICA) step later in the pipeline.
Following the initial step to load data and segment it into trials (Step 1), the workflow provides a GUI for 
removing data segments that are contaminated with random noise and cannot be easily de-noised. This step is 
particularly targeted towards the removal of channels and trials contaminated with large-amplitude or random 
noise sources that cannot be extracted easily through blind source estimation technique or filtering. The GUI 
permits interactive deletions of trials, channels and specific trials in a channel (Step 2) and keeps a log of deleted 
segments. Filtering can then be applied to exclude low and high frequency noise (Step 3). After these initial clean-
ing steps, blind source separation techniques such as ICA can then be used (Step 4, 5) to extract eye movements, 
eye blinks, electromyography artifacts, electrode discontinuity, and cardiac signals in order to recover the desired 
brain signals. At the completion of this step, a further interactive GUI enables a final data review and removal of 
trials and channels still contaminated with random noise (Step 6). Finally, the GUI provides users the options to 
interpolate the deleted channels and re-reference the data (Step 7).
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The ERPEEG toolbox contains several important features for standardized EEG data pre-processing. First, 
it incorporates interactive data visualization capabilities (Fig. 3B), allowing the user to visualize the data at each 
step of the workflow and verifying the effectiveness of the data cleaning procedure. Second, intermediate datasets 
are saved after each processing step along with other important meta-information such as the deleted trials and 
channels, and the removed artifacts (Fig. 3C, File Directory). This enables the user to easily revert to a previous 
step in the workflow, check the output of each step, and create a database of selected artifacts. Third, ERPEEG is a 
flexible platform. It allows for basic customization through the settings menu (Fig. 3C) while providing a modular 
structure for advanced users to modify the order of processing or incorporate additional steps to accommodate 
processing of different EEG projects. Finally, parameters selected through the setting menu are saved in a sepa-
rate MATLAB file. This enables future replication or assessment of the data pre-processing steps. The utility of 
ERPEEG toolbox is illustrated in preliminary data (Fig. 4) from CAN-BIND 1 project involving EEG recorded 
during Go/NoGo task in fifteen healthy controls and fifteen MDD subjects. An early version of ERPEEG toolbox 
was also successfully used in a non CAN-BIND project12.
Figure 3. A Streamlined Toolbox for Multi-site EEG Data Processing and Archiving. (A) The main graphical 
user interface (GUI) of the ERPEEG toolbox, with 7 pre-processing steps. Through this main interface, users 
select the data (by clicking on Working Folder, and Dataset), and navigate through each preprocessing step. 
Clicking on a processing step opens a new GUI associated with that step, or runs that processing step. Steps that 
are completed turn green, and uncompleted steps remain red. (B) The view button (corresponding to each step) 
provides a visual summary of data cleaning processing (e.g., plots the power spectrum). This enables monitoring 
of data cleaning progress or detecting any major errors and data distortions. (C) The setting tab allows for 
selection of user-defined parameters for each step. (D) All intermediate steps (files created in completion of 
each step) are saved in the working folder following a standardized naming convention.
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EEG Features. EEG features refer to EEG neural markers (e.g., power of alpha oscillations) that may be 
used to differentiate between two or more study groups (e.g., patients with depression from healthy controls, 
responders to treatment from non-responders). Numerous linear and non-linear algorithms are designed to 
extract neural markers from pre-processed EEG. However, these algorithms may involve subjective selection of 
several parameters by the experimenter (e.g., selection of time windows, frequency bands, or methods of transfer-
ring signals from one domain to another, or sensor to source space). To prevent subjectivity, the data processing 
algorithms should be described in great detail within the corresponding manuscript to enable future replication 
or to diagnose the cause for a lack of replication in future studies. Specifically, any subjective parameters should 
be reported. Alternatively, EEG feature algorithms and associated parameters may be shared on an accessible 
informatics platform.
Choice of statistical frameworks and machine learning algorithms. Another source of variance 
between EEG studies is the choice of statistical frameworks. In particular, the methodologies used for correct-
ing multiple comparisons or evaluating the accuracy of machine learning algorithms are among factors that 
can impact study outcomes. In multi-site multi-investigator studies, these factors can lead to different findings 
between different groups of investigators.
Addressing Multiple Comparisons. Electrophysiological brain response can be characterized across several 
dimensions (e.g., frequency, time, and space). Typical analysis of multidimensional data evaluates the significance 
of “active” elements (voxels), i.e., voxels that meet a certain threshold of statistical significance (generally t-score 
or z-score) compared to other voxels in the dataset. Traditional analysis on a voxel-wise basis involves a very large 
number of comparisons and runs the risk of Type I errors (false positives). This is known as the multiple compar-
isons problem (MCP). Several analytical frameworks can be chosen to address the MCP in neuroimaging studies. 
Classically, MCP can be addressed using voxel-wise methods such as the Bonferroni correction and others13. 
However, these methods are thought to be unnecessarily conservative and may reduce the sensitivity of detecting 
a true effect. This can alternatively lead to Type II errors (false negatives).
To address such Type II errors of these conservative approaches, cluster-based thresholding frameworks have 
been introduced14–16. Cluster-based frameworks take advantage of smoothness across one or more dimensions 
in EEG and related neuroimaging data by grouping neighboring active (or statistically significant) voxels to rep-
resent a significant cluster. In EEG recordings, spatial smoothness (i.e., across sensors) results from the inherent 
presence of volume conduction. This is particularly prominent in high-density EEG recording (e.g., >32 elec-
trodes). Smoothness may also be present in the time or frequency domain when the sampling rate of data acquisi-
tion is higher than the dynamics of scalp EEG recordings. Therefore, neurophysiologically meaningful differences 
often extend to adjacent voxels, across one or more dimensions, forming clusters of significant values.
Cluster-based frameworks are typically implemented in two steps: 1) setting a threshold-level (e.g., p < 0.05 or 
p < 0.01) for detecting statistically-significant cluster of active, neighboring voxels, and 2) calculating the p-value 
for each cluster by evaluating the probability of the cluster occurring by chance. To assess this probability, a cluster 
Figure 4. Illustration of Utility of the ERPEEG Toolbox with Pilot Data. The panels illustrate application of 
ERPEEG toolbox on pilot data from CAN-BIND project 1. Pilot data include EEG collected during affective 
Go/noGo task in 15 healthy controls and 15 MDD patients. Raw data were imported into MATLAB via 
EEGLAB9, epoched around onset of each stimulus (e.g., Go or NoGo cue superimposed on angry, happy or 
neutral faces), and preprocessed with ERPEEG toolbox. Panels A to C illustrate the outcomes of steps 2, 5, and 
6 of ERPEEG toolbox, respectively, compared visually between MDD and control groups. Panel D, illustrates 
the final cleaned ERP, outcome of step 7, compared between MDD and controls for NoGo angry face condition. 
(A,C) In both panels, x-axes depict two groups of controls and MDD, and y-axes depict channel number, while 
colors illustrate number of trials removed for each channel averaged across subjects following step 2 (panel A), 
and step 6 (panel C). (B) In both panels, the x-axis depicts the component type (e.g., component related to eye 
blinks, bad electrodes, EKG, etc), y-axis shows the subject number, and the colors depict number of components 
removed in control (top) and MDD (bottom). The matrix of deleted trials depicted in each of these images can 
be used to systematically compare the data processing across controls and patients, but also across different 
investigators, and projects.
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measure is computed for each detected cluster. Common cluster measures include: cluster-size that includes the 
number of active voxels in a cluster; cluster-maximum that is the maximum intensity voxel (e.g., highest t sta-
tistics) within a cluster, and recently a hybrid approach, cluster-mass, that involves summing all intensity values 
(e.g., summing all t statistics) within a cluster. However, these clustering methods have a well-known caveat: set-
ting the initial threshold (e.g., p < 0.05 or p < 0.01) can have a profound effect on the resulting clusters and their 
significance, thereby introducing user bias. For example, when comparing the time-frequency maps of evoked 
potentials between two conditions, as depicted in Fig. 5, varying the significance threshold value from p value of 
0.05 to 0.0001 can significantly impact the outcome measures. This can lead to discrepancy in interpretation of 
findings between researchers. To account for this, we have recently introduced the Unbiased Cluster Estimation 
(UCE)17 method, a threshold-free extension to traditional cluster-based analysis to avoid user bias. Our approach 
calculates cluster values at all relevant p-values and combines them using an averaged approach, removing the 
reliance on thresholding and considering information from multiple threshold levels. An early version of UCE 
was successfully used in a non CAN-BIND project18. In multi-site, multi-investigator, and multi-project initi-
atives such as CAN-BIND that involves several parallel projects which share common overarching aims (e.g., 
identification of biomarkers of response to antidepressants), utility of such parameter free statistical frameworks 
enable meaningful comparisons of outcomes across projects.
Prediction Accuracy in Machine Learning Algorithms. In recent years, there has been a growing interest in using 
machine learning algorithms to predict health outcomes or classify neurological disorders. Among sources of var-
iation in different EEG studies are the features used for classification and the method used to assess the prediction 
accuracy from machine learning19. Supervised machine learning is typically implemented using the following 
steps: 1) Features are computed from pre-processed EEG data. 2) Features are then used with a classifier and the 
classifier is trained to map feature vectors to an appropriate label (e.g., healthy or depression). The classifier is 
then used to predict the label of new subjects based on their features. 3) Classification accuracy of this algorithm 
is assessed. A standard method for assessing the accuracy of the trained classifier is leave-n-out (e.g., n = 1) 
cross-validation. Data are divided into small equally sized subsets, and the classifier is trained on all subsets 
except n (e.g., one), the randomly chosen validation subset, that is used to assess the accuracy of the classifier. 
The training and the test data sets are permuted, and the process is repeated until all combinations are exhausted. 
The average accuracy across iterations is then reported as the accuracy of the classifier. Variations in the use 
of cross-validation (e.g., record-wise vs. subject-wise cross-validation) can significantly impact the prediction 
Figure 5. Illustration of Utility of Unbiased Cluster Estimation Technique. Panels A to D illustrate the impact 
of varying threshold statistic on the outcome of cluster estimation. The figure is adapted with permission from 
Frehlich et al.17. Data were collected from EEG channel CZ and compared statistically between two conditions. 
Y-axses represent frequency in Hertz and x-axes time in milliseconds with time 0 indicating application of a 
transcranial magnetic stimulation pulse. Each dark pixel denotes a voxel in the time-frequency space that meets 
a statistical criteria given by the threshold statistic. The panels illustrate how changing the threshold alters the 
number, size of clusters, and interpretation of the findings in time-frequency space.
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accuracy of machine learning algorithms19. For example, as described in details by Saeb et al.19, in record-wise 
cross-validation, data are randomly divided into training and test folds irrespective of subject label. This approach 
will lead to presence of data from the same subject in both the test and the training set. It can be shown that 
record-wise cross-validation leads to significant overestimation of the accuracy compared to subject-wise com-
parisons. Therefore, the testing methodology used for machine classification should be carefully detailed and 
reported. The availability of large volumes of data through multi-site studies also provides the opportunity to 
further validate the accuracy of the trained algorithms in an independent cohort. This independent cohort could 
be a locked dataset (e.g., data from one site) that is independent from the dataset used to train and cross-validate 
the model and that can be set aside for this purpose.
Data Archiving. To enable replication of results or to understand future challenges in replicating original 
findings, archiving the outputs of intermediate analysis steps is recommended. As described in section 6, our 
customized pre-processing toolbox saves and logs the output of each EEG pre-processing step, along with the 
meta-data summarizing details of each pre-processing step (e.g., information on deleted segments, filter param-
eters, rejected artifact components, etc). Any or all of these intermediate files may be saved on the informatics 
platform for future reference and assessment of impact of data pre-processing choices on the EEG outcomes. In 
cases where multiple modalities are involved (e.g., EEG and fMRI), similar naming convention should be used for 
equivalent datasets to enable integration and cross-comparisons.
Knowledge Translation. In large-scale multi-site, multi-platform, and multi-investigator initiatives such 
as CAN-BIND, early and frequent conversations among investigators are needed to streamline the process of 
research knowledge translation. We propose that knowledge translation can be considered in two stages: Stage 
1 involves dissemination of scientific findings, including developed methodologies (such as present article) and 
research articles that originate from data collected through the projects. Stage 2 involves translation of findings 
into everyday clinical practice, including again both the developed methodology to translate findings and the 
actual practical translation of the research findings. In Stage 1, the priority of the various research hypotheses, 
the sequence in which research questions must be addressed when using common EEG datasets and the dissem-
ination of results via peer-reviewed journal articles must be reached by consensus. Specifically, in multi-platform 
projects that ultimately involve integration of data across multiple platforms (e.g., integrating EEG, fMRI, clinical, 
and genetic data, or integrating data collected in humans and animals), regular communication should take place 
between leaders of platforms on issues surrounding the standardization process to ensure that data and outcomes 
can be ultimately integrated. For example, in CAN-BIND, a web-based discussion platform (e.g., Basecamp) is 
utilized through which summary of monthly calls and meetings are shared and archived in a centralized fashion 
and made available to all participating sites and investigators. Similarly, methods and directions to be followed 
for Stage 2 of knowledge translation (e.g., handling of intellectual properties, commercialization plans) should be 
discussed early on and planned out by effective communication among investigators.
Discussion
Standardization of data collection, analysis, and handling is at the core of multi-site, multi-investigator, and 
multi-project initiatives such as CAN-BIND that involve capturing and integrating data across multiple data 
platforms (e.g. clinical, EEG, neuroimaging, and molecular). Big data collected by a research network will ulti-
mately be accessed by numerous research scientists and data analysts. Reproducibility and the ability to preserve 
and integrate study outcomes across projects and investigators are therefore integral components of the network 
and major determinants of its overall impact on improving human condition. In this paper, we described the 
measures taken and knowledge gained during standardization of the EEG platform of CAN-BIND. Many of the 
concepts and data standardization approaches introduced in this manuscript can be extended to other data plat-
forms and other EEG multi-site studies.
In this paper, we described potential sources of variance across multiple stages of a research study when EEG 
data is collected across several sites. We described factors in study design that need careful consideration to 
minimize bias in research results across sites. Moreover, examples were provided of the types of data variability 
introduced due to differences in recording equipment. In the context of the CAN-BIND multi-site project 14, 
differences in equipment was a challenge in the collection of task-based EEG (i.e., ERPs) data. We introduced a 
streamlined EEG preprocessing toolbox to standardize, assess, and track the impact of EEG data pre-processing 
decisions and subjectivity in EEG data cleaning on study outcomes. Finally, we drew attention to the impact of 
statistical frameworks on study outcome measures and introduced specific strategies aimed to attenuate such 
impacts.
The growing trend in multi-site research studies featuring integration of unstructured data across multiple 
institutions is likely here to stay. These trends are in part motivated by challenges in replicating research out-
comes across laboratories, and the lack of generalizability of research outcomes derived from underpowered 
studies. While multi-site research projects aim to address these challenges, the benefits of such initiatives may be 
hindered by several sources of inter-site variance discussed in this article. This may be an issue in the near future 
because subsequent to the establishment of independent informatics platforms and collection of data through 
multi-site trials, the scientific community will soon begin to compare findings between the platforms and trials. 
The integrity and shelf life of biological data depends on the quality, homogeneity, and proper documentation 
and handling of data and data parameters across investigators and laboratories. Therefore, timely discussion and 
establishment of recognized consensus and standards in EEG studies for wide-scale adoption would increase the 
likelihood of successful data integration and replication across informatics platforms. We propose that a compre-
hensive annotation of data and archiving of meta-data across all stages of a research study will allow for offline 
data standardization and enable re-usability of the data in novel analyses beyond the goals of the original study.
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